Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.

Some patients with the sleep apnea/hypopnea syndrome (SAHS) remain subjectively and objectively sleepy despite using effective continuous positive airway pressure (CPAP) therapy. The aim of this single center study was to determine the efficacy and safety of the novel wake-promoting medication modafinil in the treatment of CPAP-resistant daytime sleepiness. Thirty sleep apneics receiving effective CPAP therapy (objective use, 6.5 +/- 1.1 h/night) received daily single doses of 400 mg modafinil or placebo for 2 wk in a double-blind randomized crossover design. Outcome measures were assessed at baseline and at the end of both 2-wk treatment periods. Treatment periods were separated by a 1-wk washout. Modafinil had no effect on sleepiness as measured by the Epworth Sleepiness Scale or the Multiple Sleep Latency Test (p > 0.1); however, significant improvements in alertness were found with the Maintenance of Wakefulness Test (modafinil 18.3 +/- 3.9 min; placebo, 16.6 +/- 5.0 min; p < 0.02). No significant treatment-related improvements in cognitive performance or quality of life were found with modafinil (all p > 0.05). There was a significant reduction in CPAP use on modafinil compared to placebo (6.3 +/- 1 h/ night; 6.5 +/- 1, p = 0.03). This study suggests that modafinil may improve some aspects of alertness in patients with SAHS who remain sleepy during CPAP therapy, but further studies are required to assess the significance of the reduction in CPAP use.

[1]  M. Thorpy.  The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. , 1992, Sleep.

[2]  M. Mitler,et al.  Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness. , 1992, Chest.

[3]  M. Carskadon,et al.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. , 1986, Sleep.

[4]  C Guilleminault,et al.  A cause of excessive daytime sleepiness. The upper airway resistance syndrome. , 1993, Chest.

[5]  A Smiley,et al.  Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. , 1997, Thorax.

[6]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[7]  P. Achermann,et al.  Human versus porcine insulin in patients with insulin-dependent diabetes mellitus: differences in sleep and the sleep EEG during near-normoglycemia. , 1998, Sleep.

[8]  M M Mitler,et al.  Maintenance of wakefulness test in obstructive sleep apnea syndrome. , 1992, Chest.

[9]  A I Pack,et al.  An instrument to measure functional status outcomes for disorders of excessive sleepiness. , 1997, Sleep.

[10]  Crispin Jenkinson,et al.  Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial , 1999, The Lancet.

[11]  M. Mitler,et al.  Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. , 1991, Sleep.

[12]  I. Deary,et al.  Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. , 1999, American journal of respiratory and critical care medicine.

[13]  H. Moldofsky,et al.  Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy , 1997, Neurology.

[14]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .

[15]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[16]  A E Rogers,et al.  Health-related quality of life effects of modafinil for treatment of narcolepsy. , 1999, Sleep.

[17]  D. Batéjat,et al.  Interest of modafinil, a new psychostimulant, during a sixty‐hour sleep deprivation experiment , 1995, Fundamental & clinical pharmacology.

[18]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[19]  N J Douglas,et al.  The sleep hypopnea syndrome. , 1988, The American review of respiratory disease.

[20]  M. Jouvet,et al.  Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  L. Garma,et al.  Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. , 1997, Respiration; international review of thoracic diseases.

[22]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[23]  D. Fry,et al.  Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy , 1998, Annals of neurology.

[24]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[25]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[26]  R T Wilkinson,et al.  Field Test of Arousal: A Portable Reaction Timer with Data Storage , 1982, Human factors.

[27]  Christian Guilleminault,et al.  Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy , 2000, Neurology.

[28]  M. Thorpy,et al.  Short-term triazolam use improves nocturnal sleep of narcoleptics. , 1992, Sleep.

[29]  J. Montplaisir,et al.  Effects of modafinil on symptomatology of human narcolepsy. , 1993, Clinical neuropharmacology.

[30]  L. Findley,et al.  Driving simulator performance in patients with sleep apnea. , 1989, The American review of respiratory disease.

[31]  A I Pack,et al.  Night-to-night variability in CPAP use over the first three months of treatment. , 1997, Sleep.

[32]  Y. Wong,et al.  A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers , 1999, Journal of clinical pharmacology.

[33]  N J Douglas,et al.  Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. , 1992, Archives of internal medicine.

[34]  I. Deary,et al.  Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome , 1994, The Lancet.